N/A Completed N=36 Randomized Supportive Care

mPCST for BMT Patients

Stem Cell Transplant

Source: ClinicalTrials.gov NCT01984671 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2025

Primary outcomePrimary: Feasibility as Measured by the Overall Percentage of Completed Sessions — 83 percentage of sessions

Summary

We used a small randomized controlled trial (n=36) to compare a Mobile Health Pain Coping Skills (mPCST) to Usual Treatment for patients having received hematopoietic stem cell transplant.

Outcome Measures

Outcome	Result	p-value
PRIMARY Feasibility as Measured by the Overall Percentage of Completed Sessions	83	—
PRIMARY Acceptability as Measured by the Percentage of Participants Who Responded in the Affirmative for Each Item on the Assessment	80; 100; 100	—
SECONDARY Cohen's D Effect Size of the Change in Pain Disability From Baseline to 10 Weeks	0.79; 0.69	—
SECONDARY Cohen's D Effect Size of the Change in Pain Self-efficacy From Baseline to 10 Weeks	0.61; 0.10	—
SECONDARY Cohen's D Effect Size of the Change in Fatigue From Baseline to 10 Weeks	0.94; 0.81	—
SECONDARY Cohen's D Effect Size of the Change in 2-minute Walk Test From Baseline to 10 Weeks	0.66; 0.41	—

Eligibility Criteria

Inclusion Criteria

receipt of an stem cell transplant due to an oncological disease,
no prior stem cell transplant,
report a clinical pain score of at least 3/10, and
an age of > 21.

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT01984671). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.